The p53/miR-17/Smurf1 pathway mediates skeletal deformities in an age-related model via inhibiting the function of mesenchymal stem cells
Wenjia Liu(Changzhou No.2 People's Hospital), Yan Jin(St. Jude Children's Research Hospital)
Cited by 71
Related Papers
Lipopolysaccharide differentially affects the osteogenic differentiation of periodontal ligament stem cells and bone marrow mesenchymal stem cells through Toll-like receptor 4 mediated nuclear factor κB pathway
|Stem Cell Research & Therapy|2014|149
Epigenetic inhibition of Wnt pathway suppresses osteogenic differentiation of BMSCs during osteoporosis
|Cell Death and Disease|2018|147
miR-21 deficiency inhibits osteoclast function and prevents bone loss in mice
|Scientific Reports|2017|125
Gender-independent efficacy of mesenchymal stem cell therapy in sex hormone-deficient bone loss via immunosuppression and resident stem cell recovery
|Experimental & Molecular Medicine|2018|86
Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis
|Stem Cells Translational Medicine|2016|83